ArticleFrontiers in pharmacology2025

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system.

Haolin Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.